David Eldred‐Evans

Imperial College Healthcare NHS Trust, Imperial College London

Papers

Total Citations

H-Index

About

Dr. David Eldred-Evans is a leading urological researcher whose work centers on advancing the diagnosis and management of prostate cancer, with a particular focus on refining biopsy techniques. His major contributions lie in the evolution of prostate biopsy, where he has been instrumental in evaluating and implementing robotic-assisted, targeted MRI-US fusion approaches. His prospective analysis of robotic targeted biopsy using the centroid targeting method (38 citations) demonstrated the feasibility and accuracy of this emerging technology, offering a standardized, pre-programmed transperineal scheme that reduces operator variability. This work has helped pave the way for more precise and less invasive prostate cancer detection. Dr. Eldred-Evans also authored a comprehensive review on the landmarks in the evolution of prostate biopsy (43 citations), providing a critical historical and technical framework for the field. His research has directly impacted clinical practice by validating robotic biopsy as a reliable tool for improving diagnostic yield and patient outcomes. Through these influential studies, he has established himself as a key voice in the modernization of prostate cancer diagnostics, guiding both current practice and future innovation.